Point-of-Care Medication Initiation and Adherence Platform Achieves 4 Million Patient Milestone

The MedVantx MedStart Connect Program Eliminates Gaps in Primary Medication Adherence

For Over 4 Million Patients Creating Estimated $50M in Out of Pocket Savings for Consumers and Estimated $120 Million in Overall Healthcare Cost Avoidance

Apr 03, 2014, 07:10 ET from MedVantx, Inc.

SAN DIEGO, April 3, 2014 /PRNewswire/ -- MedVantx, Inc., a leading provider of point-of-care medication adherence and direct-to-patient consumer engagement programs, today announced the Company's MedStart Connect™ program has reached over 4 million consumers since the program's inception. 

MedVantx pioneered first ever consumer access to free initial generic medication therapy in U.S. physician offices through the Company's proprietary "ATM-like" medication management & sampling system, the MedStart-Connect™. Through an integrated network of 4,000 physicians, MedVantx has eliminated a key structural gap in primary medication adherence—the fact that 30-50% of initial prescriptions are never filled at the pharmacy.  The MedStart Connect program has also been shown to enhance patient satisfaction levels and has fundamentally changed the healthcare consumers' medication access experience.

Sponsored by manufacturers, health plans and health systems, the MedStart Connect program includes free initial therapy samples of medication at the point-of-care, a consumer helpline providing drug information, adherence follow-up calls and reminders, and convenient consumer home delivery.  MedStart Connect has been shown in studies to improve patient satisfaction with their physician office visit, as well as improving patient medication adherence and reducing overall healthcare costs.  Because patients receive medication immediately at the point-of-care, there are fewer barriers to patients starting their medication, and this impact has been shown to carry over into longer term use of these medications over time resulting in approx. $120 million in overall cost of care avoidance.  

"From an idea, we have grown to a company serving over 4 million consumers, and thousands of health care professionals," said Robert Feeney, CEO, MedVantx, Inc.  "Not only are we providing a valuable service to patients and consumers, we also know that our program adds value to the health care system, by improving medication adherence, thereby decreasing costs of care.  It's a true win-win."

About MedVantx, Inc.

MedVantx is an innovative medication management and delivery company committed to streamlining access, reducing healthcare costs, increasing medication adherence, and enhancing patient satisfaction while improving patient quality of care and outcomes.  The MedStart Connect program provides for a fully-automated, integrated, point-of-care to consumer home delivery channel focused on increasing the quality and cost effectiveness of the last non-managed pharmaceutical channel – the physician office sample closet.  MedStart Connect includes free initial therapy samples of prescription and over-the-counter medication at the point of care, a consumer helpline providing drug information, adherence management services, and convenient consumer home delivery through its mail order pharmacy.  The national MedVantx network has served over 4 million consumers through an integrated network including health plans, manufacturers and more than 4,000 prescribers in diverse care settings. 

For company information, visit www.medvantx.com. For information on MedStart Connect, visit www.MedStart-Connect.com.

MedVantx Contact:
JD Haldeman
(858) 625-2990 ext. 130

SOURCE MedVantx, Inc.